Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(4)

Detailed Status

Not yet recruiting4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

not_yet_recruiting4100%

Recent Activity

0 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable

Clinical and BIOgical Analyses of RECtal Tumors

NCT07499921
not_yet_recruiting

Role of MDSCs and Cancer Stem Cells and Their Cross Talks in NSCLC

NCT06024226
not_yet_recruiting

Role of Cancer-associated Fibroblast, MDSCs and Immune Cell Interplays in the Resistance of Non-small Cell Lung Cancer to Anti-PD1/PD-L1 Therapies

NCT06024538
not_yet_recruitingnot_applicable

Microenvironment and Immunity of Digestive Cancers - East Paris Multicentric Cohort

NCT04707365

Clinical Trials (4)

Showing 4 of 4 trials
NCT07499921Not Applicable

Clinical and BIOgical Analyses of RECtal Tumors

Not Yet Recruiting
NCT06024226

Role of MDSCs and Cancer Stem Cells and Their Cross Talks in NSCLC

Not Yet Recruiting
NCT06024538

Role of Cancer-associated Fibroblast, MDSCs and Immune Cell Interplays in the Resistance of Non-small Cell Lung Cancer to Anti-PD1/PD-L1 Therapies

Not Yet Recruiting
NCT04707365Not Applicable

Microenvironment and Immunity of Digestive Cancers - East Paris Multicentric Cohort

Not Yet Recruiting

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4